269 related articles for article (PubMed ID: 3466690)
1. Depletion of sodium butyrate from the culture medium of Friend erythroleukemia cells undergoing differentiation.
Friend C; Zajac-Kaye M; Holland JG; Pogo BG
Cancer Res; 1987 Jan; 47(2):378-82. PubMed ID: 3466690
[TBL] [Abstract][Full Text] [Related]
2. Antagonistic effect of butyrate on hexamethylene bisacetamide induced differentiation of murine erythroleukemia cells.
Corin RE; Haspel HC; Peretz AM; Sonenberg M; Rifkind RA
Cancer Res; 1986 Mar; 46(3):1136-41. PubMed ID: 3455880
[TBL] [Abstract][Full Text] [Related]
3. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
Chen YL; Wu RT
Cancer Res; 1994 Apr; 54(8):2192-8. PubMed ID: 7513611
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of commitment by K562 human erythroleukemia cells.
Rowley PT; Ohlsson-Wilhelm BM
Prog Clin Biol Res; 1985; 191():217-31. PubMed ID: 3863148
[TBL] [Abstract][Full Text] [Related]
5. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
Breitman TR; He RY
Cancer Res; 1990 Oct; 50(19):6268-73. PubMed ID: 2400989
[TBL] [Abstract][Full Text] [Related]
6. Evidence for multiple sites of regulation of heme synthesis in murine erythroleukemia cells.
Ebert PS; Bonkowsky HL; Deisseroth A
J Natl Cancer Inst; 1979 May; 62(5):1247-50. PubMed ID: 155751
[TBL] [Abstract][Full Text] [Related]
7. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide.
Waxman S; Scher BM; Hellinger N; Scher W
Cancer Res; 1990 Jul; 50(13):3878-87. PubMed ID: 2354439
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of erythroleukemic cells in vitro: irreversible induction by dimethyl sulfoxide (DMSO).
Preisler HD; Giladi M
J Cell Physiol; 1975 Jun; 85(3):537-46. PubMed ID: 49357
[TBL] [Abstract][Full Text] [Related]
9. Effects of activin A/erythroid differentiation factor on erythroid and megakaryocytic differentiations of mouse erythroleukemia (Friend) cells: evidence for two distinct modes of cell response.
Okafuji K; Kaku K; Seguchi M; Tanaka H; Azuno Y; Kaneko T
Exp Hematol; 1995 Mar; 23(3):210-6. PubMed ID: 7875239
[TBL] [Abstract][Full Text] [Related]
10. Bcl-XL induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization.
Hafid-Medheb K; Poindessous-Jazat V; Augery-Bourget Y; Hanania N; Robert-Lézénès J
Cell Death Differ; 1999 Feb; 6(2):166-74. PubMed ID: 10200563
[TBL] [Abstract][Full Text] [Related]
11. Dimethyl sulfoxide-induced differentiation of Friend erythroleukemia cells in the absence of cytokinesis.
Tsiftsoglou AS; Sartorelli AC
Cancer Res; 1979 Oct; 39(10):4058-63. PubMed ID: 289437
[TBL] [Abstract][Full Text] [Related]
12. Growth and differentiation of human and murine erythroleukemia cell lines in serum-free synthetic medium.
Pessano S; McNab A; Rovera G
Cancer Res; 1981 Sep; 41(9 Pt 1):3592-6. PubMed ID: 7020933
[TBL] [Abstract][Full Text] [Related]
13. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ
Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953
[TBL] [Abstract][Full Text] [Related]
14. Perturbation of growth and differentiation of Friend murine erythroleukemia cells by 5-bromodeoxyuridine incorporation in early S phase.
Brown EH; Schildkraut CL
J Cell Physiol; 1979 May; 99(2):261-78. PubMed ID: 287673
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of Friend erythroleukemic cells in media lacking fetal calf serum.
Yancheva NY; Djondjurov LP
Neoplasma; 1981; 28(6):669-73. PubMed ID: 6951111
[TBL] [Abstract][Full Text] [Related]
16. Effects of retinoic acid versus dimethyl sulfoxide on Friend erythroleukemia cell growth. I. Cell proliferation, RNA content, and protein content.
Traganos F; Bueti C; Darzynkiewicz Z; Melamed MR
J Natl Cancer Inst; 1984 Jul; 73(1):193-204. PubMed ID: 6588224
[TBL] [Abstract][Full Text] [Related]
17. The role of heme in the regulation of the late program of Friend cell erythroid differentiation.
Mager D; Bernstein A
J Cell Physiol; 1979 Sep; 100(3):467-79. PubMed ID: 489671
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of sodium butyrate, dimethyl sulfoxide, and retinoic acid on membrane-associated antigen, enzymes, and glycoproteins of human rectal adenocarcinoma cells.
Tsao D; Morita A; Bella A; Luu P; Kim YS
Cancer Res; 1982 Mar; 42(3):1052-8. PubMed ID: 7059970
[TBL] [Abstract][Full Text] [Related]
19. Erythroid differentiation and poly(ADP-ribose) synthesis in Friend leukemia cells.
Morioka K; Tanaka K; Nokuo T; Ishizawa M; Ono T
Gan; 1979 Feb; 70(1):37-46. PubMed ID: 156137
[TBL] [Abstract][Full Text] [Related]
20. Butyramide and monobutyrin: growth inhibitory and differentiating agents.
Lea MA; Xiao Q; Sadhukhan A; Sharma S; Newmark HL
Anticancer Res; 1993; 13(1):145-9. PubMed ID: 8476205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
